Overview

In this edition, we have reported on a range of recent developments, at EU and national level, relating to pharmaceutical patent litigation, regulatory updates and recent industry news. We hope you enjoy reading this update and are happy to address any comments or questions you may have, either through your usual contact or through any of the contacts on the back page of this update.

International Life Sciences Group

To read more click View Briefing